| Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
|---|---|---|---|---|---|---|---|---|---|---|---|
| JYSZ2200026 | 精蛋白人胰岛素混合注射液(30R) | human insulin;isophane protamine human insulin | Injection | Biological Products | License Renew | 2022-06-24 | Novo Nordisk (China) Pharmaceuticals Co Ltd;Novo Nordisk A/S | view |